Eyenovia Inc stops the trial for its myopia drug because the outcome was not as expected, causing Eyenovia’s share price to fall by 57%. ...
Eyenovia Inc stops the trial for its myopia drug because the outcome was not as expected, causing Eyenovia’s share price to fall by 57%. ...
Join our subscribers list to get the latest news, updates and special offers delivered directly in your inbox.